Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander John Denner, also known as Alex PhD.
Medicines Co (MDCO)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Market Movers Today: Tenax Therapeutics Inc (TENX), Overstock.com Inc (OSTK), Box Inc (BOX), Patterson Companies, Inc. (PDCO), and More
Tenax Therapeutics Inc shares surged 140.5 percent to $ 11.16 as the company reported the publication of preclinical data showing added evidence of levosimendan treatment effects in pulmonary hypertension...
This Fund's Picks Gained 200% In A Year And Why No One Knows About It
You probably haven't heard of Alex Denner's Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued at $1 billion or more delivered...
13G Filing: Partner Fund Management and Medicines Co (MDCO)
You can access the original SEC filing by clicking here.
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc.
Hedge Funds Are Betting On The Medicines Company (MDCO)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...
Movers In Biotech: Cellectar Biosciences Inc (CLRB) And The Medicines Company (MDCO)
We’ve had another big day in biotech, and a number of companies have moved on news and fundamental developments.
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Decsontructing The Latest The Medicines Company (MDCO) Release
The Medicines Company (NASDAQ:MDCO) just put out topline from its lead cholesterol trial, and the company has jumped on the back of the data.
Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
